The "FDA's New Import Program for 2018 - Strict Precision" conference has been added to ResearchAndMarkets.com's offering.
The "FDA's New Import Program for 2018 - Strict Precision" conference has been added to ResearchAndMarkets.com's offering.
FDA's import and export program is complex and keeps changing. The FDA's and the U.S. Custom's new import and enforcement program operates with a streamlined computer system and can leave firms at a loss to understand the short term and long term effects of a detained shipment. The law now requires foreign firms to register and submit specific information to enter U.S. commerce.
Foreign establishments are subject to FDA inspections and quality testing. Failing either FDA activity typically prevents a foreign firm's product from entering U.S. commerce. If product is detained, resolving the problem with FDA is time consuming, expensive and uncertain. Without an adequate or informed approach to your import program, the specialized federal government process and roadblocks can seem impossible to overcome. To compound the problems, working with foreign establishments presents inherent difficulties based on cultural differences business practices and language barriers.
Other foreign and domestic and legal requirements intersect with FDA's import and export program, some for the better, some not. For example, not all foreign firms are treated the same under the FDA's law. A clear example is the FDA's uses of automatic detention based on the country of origin, type of product or an establishment's history. With the growing use of off-shore operations, managing imported products can and does present obvious and hidden.
Learning Objectives:
For more information about this conference visit https://www.researchandmarkets.com/research/sn4bwv/2_day_seminar?w=4
View source version on businesswire.com: http://www.businesswire.com/news/home/20180112005257/en/